TheHER2CISH pharmDx™Kit in the assessment of breast cancer patients for anti-HER2 treatment
Author:
Publisher
Informa UK Limited
Subject
Genetics,Molecular Biology,Molecular Medicine,Pathology and Forensic Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1586/erm.13.6
Reference56 articles.
1. The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti–HER-2 Therapy and Personalized Medicine
2. Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer
3. Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer
4. Adjuvant Trastuzumab in HER2-Positive Breast Cancer
5. Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Bioinformatics analyses suggest that mutations in COL12A1 and its miRNAs promote stomach adenocarcinoma via loss of COL12A1 suppression;Oncologie;2023-05-16
2. Secondary Structure and Conformational Stability of the Antigen Residues Making Contact with Antibodies;The Journal of Physical Chemistry B;2021-10-07
3. Analysis of Binding Modes of Antigen–Antibody Complexes by Molecular Mechanics Calculation;Journal of Chemical Information and Modeling;2021-05-03
4. Chromogenic and Silver in Situ Hybridization for Identification of HER 2 Overexpression in Breast Cancer Patients: A Systematic Review and Meta-Analysis;Applied Immunohistochemistry & Molecular Morphology;2019-05-23
5. Her2Net: A Deep Framework for Semantic Segmentation and Classification of Cell Membranes and Nuclei in Breast Cancer Evaluation;IEEE Transactions on Image Processing;2018-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3